Tuberculosis in patients receiving treatment of TNF-alpha inhibitors

Sermin Börekçi (Istanbul, Turkey), Sermin Borekci, Deniz Demir Yilmaz, Ersan Atahan, Yesim Ozguler, Benan Musellim, Vedat Hamuryudan, Hurrem Gul Ongen

Source: International Congress 2015 – Case series and clinical conundrums in TB
Session: Case series and clinical conundrums in TB
Session type: Thematic Poster Session
Number: 2754
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Sermin Börekçi (Istanbul, Turkey), Sermin Borekci, Deniz Demir Yilmaz, Ersan Atahan, Yesim Ozguler, Benan Musellim, Vedat Hamuryudan, Hurrem Gul Ongen. Tuberculosis in patients receiving treatment of TNF-alpha inhibitors. Eur Respir J 2015; 46: Suppl. 59, 2754

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Restarting biologic agents in rheumatology patients who developed tuberculosis under TNFα-inhibitor treatment
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015

Statin use and the risk of tuberculosis: Data from 305,142 patients
Source: International Congress 2016 – New insights into aspects of tuberculosis epidemiology
Year: 2016


Detection of tuberculosis in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


The feature of BCG complications in children
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


Tuberculosis (TB) and depression
Source: Annual Congress 2013 –Tuberculosis: clinical aspects
Year: 2013

Multiplexed cytokine and chemokine profiling in patients with latent tuberculosis infection: Treatment effect
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

The effectiveness of pulmonary TB treatment in patients with organic liver diseases, depending on the way of administration of anti-TB drugs
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016


Chloroquine as a potential adjunctive therapy in tuberculosis
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014


Cholecalciferol supplementation in patients taking anti tuberculosis treatment
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014


Blood and urine IP-10 associate with active TB in HIV-infected patients
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016

Rapid monitoring of tuberculosis treatment response: A multi-centre study
Source: International Congress 2016 – Advances in tuberculosis diagnosis and monitoring of treatment
Year: 2016



Impact of drug injection using on TB-AIDS treatment outcomes
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013

Features of pulmonary tuberculosis in migrants
Source: International Congress 2015 – Epidemiology of TB: deaths, co-morbidities, migration and children
Year: 2015

Patients over 35 years experience more side-effects during latent TB treatment: Experience from an urban hospital with a high incidence of Tuberculosis
Source: International Congress 2015 – Treatment of TB (MDR-TB): co-morbidities, adverse effects and outcomes
Year: 2015


Risk factors for disseminated tuberculosis
Source: International Congress 2014 – Tuberculosis: epidemiology and public health
Year: 2014

Severe tuberculosis forms in children in Romania
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management I
Year: 2013


The particularities of new cases of tuberculosis at homeless people
Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II
Year: 2013


Range of additional drug resistance of M.tuberculosis in XDR-TB patients
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016


Immunodiagnosis of tuberculosis infection in children under the age of five - Which testing is feasible?
Source: International Congress 2015 – Paediatric bronchology
Year: 2015

Tuberculosis - Basics in diagnosis and treatment
Source: ERS Skills Course 2017 - Summer school of paediatric respiratory medicine
Year: 2017